Chaperone/Protein Folding, cyclophilin 14 CYP14
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0016020 | membrane | 2 | 9 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4IB72
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0018193 | peptidyl-amino acid modification | 5 | 11 |
GO:0018208 | peptidyl-proline modification | 6 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:0006457 | protein folding | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016853 | isomerase activity | 2 | 11 |
GO:0016859 | cis-trans isomerase activity | 3 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:0005488 | binding | 1 | 1 |
GO:0016018 | cyclosporin A binding | 4 | 1 |
GO:0033218 | amide binding | 2 | 1 |
GO:0042277 | peptide binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 8 | 14 | PF00089 | 0.507 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 253 | 255 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 436 | 438 | PF00675 | 0.740 |
CLV_PCSK_FUR_1 | 135 | 139 | PF00082 | 0.456 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.482 |
CLV_PCSK_KEX2_1 | 366 | 368 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 438 | 440 | PF00082 | 0.723 |
CLV_PCSK_PC1ET2_1 | 366 | 368 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 438 | 440 | PF00082 | 0.723 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 310 | 314 | PF00082 | 0.482 |
DEG_APCC_DBOX_1 | 137 | 145 | PF00400 | 0.650 |
DEG_APCC_DBOX_1 | 309 | 317 | PF00400 | 0.282 |
DEG_Kelch_Keap1_1 | 71 | 76 | PF01344 | 0.703 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.784 |
DEG_ODPH_VHL_1 | 385 | 398 | PF01847 | 0.482 |
DOC_CYCLIN_RxL_1 | 134 | 145 | PF00134 | 0.646 |
DOC_MAPK_DCC_7 | 20 | 30 | PF00069 | 0.716 |
DOC_MAPK_gen_1 | 135 | 143 | PF00069 | 0.666 |
DOC_MAPK_MEF2A_6 | 135 | 143 | PF00069 | 0.654 |
DOC_MAPK_MEF2A_6 | 152 | 161 | PF00069 | 0.570 |
DOC_MAPK_MEF2A_6 | 180 | 189 | PF00069 | 0.392 |
DOC_PP1_RVXF_1 | 14 | 20 | PF00149 | 0.686 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.757 |
DOC_USP7_MATH_1 | 312 | 316 | PF00917 | 0.280 |
DOC_USP7_MATH_2 | 300 | 306 | PF00917 | 0.362 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.271 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.775 |
LIG_14-3-3_CanoR_1 | 138 | 144 | PF00244 | 0.647 |
LIG_14-3-3_CanoR_1 | 152 | 161 | PF00244 | 0.539 |
LIG_14-3-3_CanoR_1 | 310 | 320 | PF00244 | 0.282 |
LIG_14-3-3_CanoR_1 | 408 | 414 | PF00244 | 0.478 |
LIG_14-3-3_CanoR_1 | 48 | 54 | PF00244 | 0.786 |
LIG_Actin_WH2_2 | 201 | 218 | PF00022 | 0.353 |
LIG_BRCT_BRCA1_1 | 323 | 327 | PF00533 | 0.282 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.338 |
LIG_FHA_2 | 140 | 146 | PF00498 | 0.671 |
LIG_FHA_2 | 153 | 159 | PF00498 | 0.569 |
LIG_FHA_2 | 425 | 431 | PF00498 | 0.412 |
LIG_LIR_Nem_3 | 219 | 225 | PF02991 | 0.314 |
LIG_SH2_NCK_1 | 348 | 352 | PF00017 | 0.362 |
LIG_SH2_NCK_1 | 393 | 397 | PF00017 | 0.448 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.355 |
LIG_SH2_STAT3 | 336 | 339 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.417 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 369 | 372 | PF00017 | 0.362 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.621 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.724 |
LIG_SUMO_SIM_anti_2 | 155 | 161 | PF11976 | 0.561 |
LIG_SUMO_SIM_par_1 | 139 | 146 | PF11976 | 0.657 |
LIG_TRAF2_1 | 427 | 430 | PF00917 | 0.395 |
LIG_TYR_ITIM | 220 | 225 | PF00017 | 0.374 |
LIG_ULM_U2AF65_1 | 437 | 442 | PF00076 | 0.686 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.751 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.717 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.601 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.463 |
MOD_CK2_1 | 424 | 430 | PF00069 | 0.514 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.741 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.324 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.705 |
MOD_GlcNHglycan | 409 | 412 | PF01048 | 0.594 |
MOD_GlcNHglycan | 432 | 435 | PF01048 | 0.716 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.714 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.724 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.401 |
MOD_GSK3_1 | 223 | 230 | PF00069 | 0.503 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.426 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.715 |
MOD_GSK3_1 | 376 | 383 | PF00069 | 0.508 |
MOD_GSK3_1 | 420 | 427 | PF00069 | 0.471 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.775 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.757 |
MOD_N-GLC_1 | 227 | 232 | PF02516 | 0.447 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.719 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.480 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.409 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.686 |
MOD_NEK2_1 | 380 | 385 | PF00069 | 0.502 |
MOD_NEK2_1 | 392 | 397 | PF00069 | 0.491 |
MOD_PIKK_1 | 424 | 430 | PF00454 | 0.678 |
MOD_PK_1 | 216 | 222 | PF00069 | 0.395 |
MOD_PKA_1 | 253 | 259 | PF00069 | 0.335 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.335 |
MOD_PKA_2 | 407 | 413 | PF00069 | 0.624 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.757 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.738 |
MOD_Plk_4 | 139 | 145 | PF00069 | 0.566 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.396 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.319 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.747 |
MOD_SUMO_for_1 | 125 | 128 | PF00179 | 0.685 |
MOD_SUMO_rev_2 | 332 | 338 | PF00179 | 0.480 |
MOD_SUMO_rev_2 | 397 | 405 | PF00179 | 0.511 |
TRG_DiLeu_BaLyEn_6 | 39 | 44 | PF01217 | 0.743 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 222 | 225 | PF00928 | 0.374 |
TRG_ENDOCYTIC_2 | 348 | 351 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.503 |
TRG_ER_diArg_1 | 135 | 138 | PF00400 | 0.680 |
TRG_ER_diArg_1 | 436 | 439 | PF00400 | 0.676 |
TRG_NES_CRM1_1 | 151 | 166 | PF08389 | 0.567 |
TRG_NLS_MonoCore_2 | 436 | 441 | PF00514 | 0.686 |
TRG_NLS_MonoExtN_4 | 437 | 442 | PF00514 | 0.686 |
TRG_Pf-PMV_PEXEL_1 | 152 | 156 | PF00026 | 0.470 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJJ3 | Leptomonas seymouri | 69% | 98% |
A0A1X0P6T5 | Trypanosomatidae | 77% | 100% |
A0A3S7X941 | Leishmania donovani | 100% | 100% |
A0A422NQ98 | Trypanosoma rangeli | 72% | 100% |
A4HMJ2 | Leishmania braziliensis | 82% | 100% |
C9ZZI1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 69% | 100% |
E9AEZ3 | Leishmania major | 94% | 100% |
E9B649 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5BP10 | Trypanosoma cruzi | 71% | 100% |